Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03828487 · ClinicalTrials.gov registry record · NA
Performance Comparison of Masimo O3 Regional Oximetry Sensors in Neonates
A NA study, sponsored by Masimo Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03828487 is a NA study that was terminated before completion, run by Masimo Corporation. The registered enrollment target is 8 participants.
The verdict
NCT03828487, a NA study, was terminated before completion, sponsored by Masimo Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The aim of the study is to compare the performance of the O3 cerebral oximeter and sensor to a 510(k) cleared NIRS (Near-Infrared Spectroscopy) device on neonatal subjects based on data collected from the cutaneously placed forehead sensors. Due to the design of the systems, the devices will be used serially instead of concurrently. Because of this timing, changes in patient state may not be reflected in measurements collected by both devices.
Interventions
- DEVICE Masimo O3 Neonatal Sensors
- DEVICE 510(k) cleared sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-12-19 |
| Est. Completion | 2019-06-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03828487
The ClinicalTrials.gov registry entry for NCT03828487 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Masimo O3 Neonatal Sensors is the first listed.
NCT03828487 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03828487 about?
NCT03828487 is a clinical study titled "Performance Comparison of Masimo O3 Regional Oximetry Sensors in Neonates". The aim of the study is to compare the performance of the O3 cerebral oximeter and sensor to a 510(k) cleared NIRS (Near-Infrared Spectroscopy) device on neonatal subjects based on data collected from the cutaneously placed forehead sensors. Due to the design of the systems, the devices will be used...
What is the current status of trial NCT03828487?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2018-12-19. Estimated completion is 2019-06-14.
What interventions are being tested in trial NCT03828487?
The interventions under investigation include: Masimo O3 Neonatal Sensors (DEVICE), 510(k) cleared sensor (DEVICE).
Who is sponsoring clinical trial NCT03828487?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.